UPC APP 37868/2024

—·EP2196231: System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.
Vertreter: Charlotte Garnitsch (Taylor Wessing); Wim Maas (Taylor Wessing); Alexander Rubusch (Taylor Wessing)
Beklagte
Roche Diabetes Care GmbH
Vertreter: Christof Augenstein (Kather Augenstein); Katharina Brandt (Kather Augenstein); Robert Knaps (Kather Augenstein); Thomas Kronberger (Grünecker Patent- und Rechtsanwälte PartGmbH)
Division: Paris CD
Richter: Paolo Catallozzi · Presiding Judge / Judge-Rapporteur
Technology: Pharmaceutical & Medical
Sprache: —
Erste Entscheidung: 27. Juni 2024

Entscheidungen

2024-06-27
Generic application
Order of the Paris Central Division (judge-rapporteur Catallozzi) granting Roche Diabetes Care GmbH's application for extension of the deadline for filing its rejoinder to the reply to the defence in a revocation action for EP 2 196 231. Roche argued that Tandem Diabetes Care submitted new prior art in their reply that had not previously been discussed, and that it needed additional time to address both the new prior art and a parallel counterclaim for revocation before the Hamburg Local Division. The court extended the deadline to 29 July 2024, exercising its discretionary power under principles of proportionality, flexibility, fairness and equity.
Rechtsfragen:Extension of time for rejoinder where new prior art introducedInteraction between central revocation and counterclaim for revocationDiscretionary time extension under proportionality and fairness principles

Dokumente